Alexander Dushkin

Dr. Alexander Dushkin

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
MAMaxim S. Afanasiev
Maxim S. Afanasiev
ADAlexander Dushkin
Alexander Dushkin
TGTatyana G. Grishacheva
Tatyana G. Grishacheva
SAStanislav S. Afanasiev
Stanislav S. Afanasiev
AKAlexander Karaulov
Alexander Karaulov

22 March 2021 in Case Reports in Oncology
Verified
Journal Article
Open access
PDF file
MAMaxim Afanasiev
Maxim Afanasiev
ADAlexander Dushkin
Alexander Dushkin
TGTatyana Grishacheva
Tatyana Grishacheva
SAStanislav Afanasiev
Stanislav Afanasiev
YNYuri Nesvizhsky
Yuri Nesvizhsky
APAndrey Pylev
Andrey Pylev
Cervical cancer is an important problem in women’s health and a worldwide oncological disease. In 2018, the WHO registered 569,847 new cases in the world, and 3.4% were in the Russian Federation. We describe here a case of invasive cervical cancer stage IB2 associated with human papilloma virus in a woman who was treated by multicourse photodynamic therapy (PDT). A 38-year-old woman presented with abdominal pain and genital tract spotting in October 2015. Colposcopy revealed a neoplasm in cauliflower form. PAP smear result was cancer in situ (Tis). The biopsy result from the cervical canal and neoplasm was invasive squamous cell carcinoma. The patient underwent full preoperative examination (blood test, biochemical blood test, coagulation test, urinalysis, X-ray of chest organs, ECG, ultrasound investigation of pelvic organs, and PAP smear). Magnetic resonance imaging investigation showed a heterogeneous tumor, uneven contours, and intensity accumulating contrast. The patient was not pregnant, and a fertility-preserving treatment method was used. Three PDT sessions allowed to avoid vaginal radical trachelectomy. Pregnancy occurred 3 years and 8 months after the first PDT session. The patient had testing after treatment 4 times (3rd, 12th, 24th, and 60th months). She had a pregnancy without complications and had operative delivery by Cesarean section in April 2020. There was a 5-year remission period without episodes of relapse. The patient has an 8-month-old baby.

28 July 2022 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
ADAlexander Dushkin
Alexander Dushkin
MAMaxim Afanasiev
Maxim Afanasiev
SAStanislav Afanasiev
Stanislav Afanasiev
PKPolina Kukina
Polina Kukina
APAndrey Pylev
Andrey Pylev
AKAlexander Karaulov
Alexander Karaulov

17 August 2023 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
ADAlexander Dushkin
Alexander Dushkin
MAMaxim Afanasiev
Maxim Afanasiev
TGTatyana Grishacheva
Tatyana Grishacheva
APAndrey Pylev
Andrey Pylev
MBMikhail Burdykov
Mikhail Burdykov
AKAlexander Karaulov
Alexander Karaulov

Verified
Journal Article
Open access
PDF file
ADAlexander Dushkin
Alexander Dushkin
MAMaxim Afanasiev
Maxim Afanasiev
САСтанислав Степанович Афанасьев
Станислав Степанович Афанасьев
TGTatiana Grishacheva
Tatiana Grishacheva
IVIrina I. Vlasova
Irina I. Vlasova
AKAlexander Karaulov
Alexander Karaulov
We present the findings of assessing the expression levels of extracellular TLR2 and TLR4 and intracellular TLR3 and TLR8 correlating with the severity of clinical manifestations of HPV infection. A total of 199 women took part in a single-center prospective comparative research study on TLR2, TLR3, TLR4 and TLR8 expression in HPV-related cervical lesions. TLRs’ mRNA expression was analyzed using real-time reverse transcription polymerase chain reaction (RT-PCR). Our results indicate the potential significance of TLR3, TLR4 and TLR8 in responding to HPV infection and its progression to SILs and CC, highlighting the importance of HPV polyinfection in relation to TLR4 and TLR8.

15 April 2024 in Russian Journal of Allergy
Verified
Journal Article
Open access
PDF file
DFDaria S. Fomina
Daria S. Fomina
MLMarina S. Lebedkina
Marina S. Lebedkina
ENEkaterina A. Nikitina
Ekaterina A. Nikitina
ADAlexander Dushkin
Alexander Dushkin
ACAnton A. Chernov
Anton A. Chernov
ЮДЮхновская Юлия Дмитриевна
Юхновская Юлия Дмитриевна
BACKGROUND: An important advance in modern allergology has been made by the introduction of allergenic molecules/components, including their detection by the ImmunoCAP ISAC method. This method is useful in patients with a complex spectrum of sensitization and severe forms of allergic diseases, where various predictors of severe course are actively searched for. AIM: To evaluate the informativeness of component resolved diagnostic by ISAC ImmunoCAP method in patients with severe bronchial asthma and severe atopic dermatitis. MATERIALS AND METHODS: A single-center retrospective study was conducted from January to August 2023. 100 patients who were candidates for biologicals for severe bronchial asthma (group 1; 63 patients), severe atopic dermatitis (group 2; 20 patients), or their combination (group 3; 17 patients) were included. Component restlved diagnostic was performed by ImmunoCAP ISAC method. RESULTS: Polysensitization and high occurrence of food and fungal allergens were more frequently detected in the groups of patients with severe atopic dermatitis. When analyzing the pollen sensitization spectrum in groups 2 and 3, Bet v 1 and PR-10 family cross-linked molecules (Mal d 1, Pru p 1, Ara h 8, Gly m 4, Cor a 1.04), as well as Ole e 9, Cyn d 1, Ph p 1 and Par j 2 were the most common. Epidermal allergens were common in all three groups. Lipocains (Can f 1, Can f 4, Can f 6, Ecu q 1, Mus m 1), kallikreins (Can f 5), and albumin (Fel d 2) dominated among them. The presence of sensitization to household allergens was detected only in group 2 and only to the molecule Der p 23. Among fungal allergens, the allergen Asp f 6 was predominant in the groups with severe atopic dermatitis, and the component Alt a 1 in patients with severe bronchial asthma. Among food allergens, one of the most common allergens was the molecule Gad c 1, Gal d 1, Gal d 2, Gal d 5 and Bos d 6. CONCLUSION: Component resolved diagnostic is an accurate assay suitable for determining the spectrum of sensitization in patients; its result can serve as a distinct biomarker for severe allergic diseases.